Acquired resistance to epidermal growth factor receptor kinase inhibitors associated with a novel T854A mutation in a patient with EGFR-mutant lung adenocarcinoma.
EGFR 突变型肺腺癌患者出现新的 T854A 突变，导致对表皮生长因子受体激酶抑制剂产生耐药性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-08-0151
Bean James, Riely Gregory J, Balak Marissa, Marks Jenifer L, Ladanyi Marc, Miller Vincent A, Pao William
